All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2024-D-2484
Purpose and Content of Use-Related Risk Analyses for Drugs, Biological Products and Combination Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
Documents
2
Comments
23
Description
OPEN
Key Dates
Comment Period OpensJul 9, 2024
Comment Period ClosesSep 10, 2024
Documents
Comment Statistics
Total Comments
23
Keywords
CDER
CDRH
OC
CBER
Guidance for Industry
Purpose and Content of Use-Related
Risk Analyses for Drugs,
Biological Products and Combination Products
OPEN
Data from Regulations.gov